Skip to Main Content

Paper Details

A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor.
Nat Chem Biol
25
2017
AR, AR-mutant prostate cancer cells, CLOUD, PPC, androgen, androgen receptor, cancer, cancer cell, flutamide, patients, phenprocoumon, prostate cancer
Author NameAffiliation
Michael SchusterCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Christoph BockCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Christoph BockMax Planck Institute for Informatics
Christoph BockMedical University of Vienna
Christoph BockCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Christoph BockMedical University of Vienna
Christoph BockMax Planck Institute for Informatics
J??rg MencheCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Stefan KubicekCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Stefan KubicekCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
  • 1 - 10

Datasets

Release 1.2